Cargando…

In vivo confirmation of altered hepatic glucose metabolism in patients with liver fibrosis/cirrhosis by (18)F-FDG PET/CT

OBJECTIVE: The aim of this study was to assess the value of (18)F-FDG PET/CT for quantitative assessment of hepatic metabolism in patients with different stages of liver fibrosis/cirrhosis. MATERIALS AND METHODS: (18)F-FDG PET/CT scans of 37 patients either with or without liver fibrosis/cirrhosis,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verloh, Niklas, Einspieler, Ingo, Utpatel, Kirsten, Menhart, Karin, Brunner, Stefan, Hofheinz, Frank, van den Hoff, Jörg, Wiggermann, Philipp, Evert, Matthias, Stroszczynski, Christian, Hellwig, Dirk, Grosse, Jirka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226405/ https://www.ncbi.nlm.nih.gov/pubmed/30414009 http://dx.doi.org/10.1186/s13550-018-0452-y

Ejemplares similares

(18)F-FDG PET/CT-derived total lesion glycolysis predicts abscess formation in patients with surgically confirmed infective endocarditis: Results of a retrospective study at a tertiary center
por: Sag, Sabine Julia Maria, et al.
Publicado: (2023)

Full-Core Biopsy Systems Take Larger Liver Tissue Samples with Lower Fragmentation Rates Than Conventional Side-Notch Systems: A Randomized Trial
por: Schaible, Jan, et al.
Publicado: (2020)

Diagnostic performance of Gd-EOB-DTPA-enhanced MRI for evaluation of liver dysfunction: a multivariable analysis of 3T MRI sequences
por: Verloh, Niklas, et al.
Publicado: (2018)

Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation
por: Verloh, Niklas, et al.
Publicado: (2015)

Gd-EOB-DTPA-enhanced MR relaxometry for the detection and staging of liver fibrosis
por: Haimerl, Michael, et al.
Publicado: (2017)

Detecting liver fibrosis with Gd-EOB-DTPA-enhanced MRI: A confirmatory study
por: Verloh, Niklas, et al.
Publicado: (2018)

DWI - histology: a possible means of determining degree of liver fibrosis?
por: Verloh, Niklas, et al.
Publicado: (2018)

Primary efficacy of percutaneous microwave ablation of malignant liver tumors: comparison of stereotactic and conventional manual guidance
por: Schaible, Jan, et al.
Publicado: (2020)

Case Report: Extramedullary Acute Promyelocytic Leukemia: An Unusual Case and Mini-Review of the Literature
por: Harrer, Dennis Christoph, et al.
Publicado: (2022)

Differentiated Thyroid Cancer—Treatment: State of the Art
por: Schmidbauer, Benedikt, et al.
Publicado: (2017)

Assessment of Clinical Signs of Liver Cirrhosis Using T1 Mapping on Gd-EOB-DTPA-Enhanced 3T MRI
por: Haimerl, Michael, et al.
Publicado: (2013)

Influence of hepatic fibrosis and inflammation: Correlation between histopathological changes and Gd-EOB-DTPA-enhanced MR imaging
por: Verloh, N., et al.
Publicado: (2019)

Identification and In-Depth Analysis of the Novel FGFR2-NDC80 Fusion in a Cholangiocarcinoma Patient: Implication for Therapy
por: Scheiter, Alexander, et al.
Publicado: (2021)

Diagnostic value of FDG PET/CT imaging in patients with surgically managed infective endocarditis: results of a retrospective analysis at a tertiary center
por: Sag, Sabine Julia Maria, et al.
Publicado: (2020)

Improvement of the Primary Efficacy of Microwave Ablation of Malignant Liver Tumors by using a Robotic Navigation System
por: Schaible, Jan, et al.
Publicado: (2020)

FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma—An Updated Overview
por: Voltin, Conrad-Amadeus, et al.
Publicado: (2020)

Monitoring scanner calibration using the image-derived arterial blood SUV in whole-body FDG-PET
por: Maus, Jens, et al.
Publicado: (2018)

An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2016)

Dual time point based quantification of metabolic uptake rates in (18)F-FDG PET
por: den Hoff, Jörg van, et al.
Publicado: (2013)

Comparative evaluation of SUV, tumor-to-blood standard uptake ratio (SUR), and dual time point measurements for assessment of the metabolic uptake rate in FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2016)

Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2019)

Volume-Assisted Estimation of Remnant Liver Function Based on Gd-EOB-DTPA Enhanced MR Relaxometry: A Prospective Observational Trial
por: Verloh, Niklas, et al.
Publicado: (2023)

Quantitative Evaluation of Enhancement Patterns in Focal Solid Liver Lesions with Gd-EOB-DTPA-Enhanced MRI
por: Haimerl, Michael, et al.
Publicado: (2014)

Changes in gadoxetic-acid-enhanced MR imaging during the first year after irreversible electroporation of malignant hepatic tumors
por: Bäumler, Wolf, et al.
Publicado: (2020)

FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials
por: Kaddu-Mulindwa, Dominic, et al.
Publicado: (2021)

Quantification of contrast agent uptake in the hepatobiliary phase helps to differentiate hepatocellular carcinoma grade
por: Haimerl, Michael, et al.
Publicado: (2021)

Total lesion glycolysis in oral squamous cell carcinoma as a biomarker derived from pre-operative FDG PET/CT outperforms established prognostic factors in a newly developed multivariate prediction model
por: Spanier, Gerrit, et al.
Publicado: (2021)

Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: Comparison between signal-intensity-based indices and T1 relaxometry
por: Haimerl, Michael, et al.
Publicado: (2017)

Diagnostic Accuracy of Indocyanine Green Clearance Test for Different Stages of Liver Fibrosis and Cirrhosis
por: Luerken, Lukas, et al.
Publicado: (2023)

MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score
por: Haimerl, Michael, et al.
Publicado: (2014)

Evaluation of Alterations to Bile Ducts and Laboratory Values During the First 3 Months After Irreversible Electroporation of Malignant Hepatic Tumors
por: Bäumler, Wolf, et al.
Publicado: (2020)

Comparison of different tube-of-response (TOR) models for resolution recovery in PET image reconstruction for the Philips Ingenuity TF PET/MR
por: Lougovski, Alexandr, et al.
Publicado: (2015)

A convolutional neural network for fully automated blood SUV determination to facilitate SUR computation in oncological FDG-PET
por: Nikulin, Pavel, et al.
Publicado: (2020)

Asphericity derived from [(18)F]FDG PET as a new prognostic parameter in cervical cancer patients
por: Cegla, Paulina, et al.
Publicado: (2023)

The PET-derived tumor-to-blood standard uptake ratio (SUR) is superior to tumor SUV as a surrogate parameter of the metabolic rate of FDG
por: van den Hoff, Jörg, et al.
Publicado: (2013)

Prognostic Value of Pretherapeutic Primary Tumor MTV from [(18)F]FDG PET in Radically Treated Cervical Cancer Patients
por: Cegla, Paulina, et al.
Publicado: (2021)

Similar Complication Rates for Irreversible Electroporation and Thermal Ablation in Patients with Hepatocellular Tumors
por: Verloh, Niklas, et al.
Publicado: (2019)

Correction: Similar Complication Rates for Irreversible Electroporation and Thermal Ablation in Patients with Hepatocellular Tumors
por: Verloh, Niklas, et al.
Publicado: (2023)

Application of A U-Net for Map-like Segmentation and Classification of Discontinuous Fibrosis Distribution in Gd-EOB-DTPA-Enhanced Liver MRI
por: Strotzer, Quirin David, et al.
Publicado: (2022)

Candida Endocarditis in Patients with Candidemia: A Single-Center Experience of 14 Cases
por: Hitzenbichler, Florian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_358oeavcsrr3c21v6vfcsc658i